Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TC Energy Corporation Common Stock (TRP) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

TC Energy Corporation Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

TC Energy Corporation Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? TC Energy Corporation Common Stock trades at $61.12 (market cap $63.97B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: TC Energy Corporation Common Stock is far larger — about 35.5× Vir Biotechnology Inc. Common Stock's market cap, and TC Energy Corporation Common Stock pays a 4.02% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold TC Energy Corporation Common Stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

TRPVIR
Market Cap
$63.97B$1.80B
Volume
3,039,2801,782,836
Sector
EnergyHealth
52-Week High
$70.91$11.78
52-Week Low
$49.79$5.12
Typical Hold Time
6 Days0 Days
Enterprise Value
$108.73B$1.36B
Dividend Yield
4.02%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

TC Energy Corporation Common Stock

TRP trades at $61.55, up 1.63% with a bullish technical signal despite mixed moving averages. The company shows solid fundamentals with $15.24B revenue, 22.91% net margin, and consistent EBITDA growth. Recent developments include Coastal GasLink Phase 2 expansion approval and a $400M pipeline divestiture, positioning for long-term natural gas demand growth. Analyst consensus is strongly bullish with a $85 price target representing 38% upside potential.

TRP presents a compelling investment case with strong profitability, strategic growth initiatives, and overwhelming analyst support. Key risks include execution challenges on major projects, interest rate sensitivity, and energy market volatility. The stock's current valuation at 25x P/E appears reasonable given growth prospects and 4.3% dividend yield, though technical indicators suggest near-term consolidation may occur.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TRP

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About TC Energy Corporation Common Stock

TC Energy operates energy infrastructure, including natural gas pipelines and storage systems. Its assets transport energy across North America.

Read more on TRP →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →